STERISHEALTHCARE Products
Mumbai 08042755542 info@sterispharma.com
91918824471531
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
Home Products ceftriaxone tazobactam injection uses
COD not available
GENERAL RANGE by Proceftazo 1125

ceftriaxone tazobactam injection uses

INR 152 INR 216
You Save: INR 64 (29.63%)
Check On Buynow
Share with
Buynow
Share this on :

Description

Product details

Proceftazo 1125 is a powerful combination antibiotic injection containing Ceftriaxone and Tazobactam, formulated to treat a wide range of serious bacterial infections. This combination enhances antibacterial effectiveness by not only killing bacteria but also preventing resistance mechanisms that often reduce the impact of standard antibiotics. Proceftazo 1125 is commonly administered in hospitals or clinical settings for moderate to severe infections requiring immediate and effective treatment. What is Proceftazo 1125 Injection? Proceftazo 1125 is a dual-action antibiotic therapy combining: Ceftriaxone (1000 mg approx.) – a third-generation cephalosporin antibiotic that kills bacteria by disrupting their cell wall formation. Tazobactam (125 mg approx.) – a beta-lactamase inhibitor that protects Ceftriaxone from bacterial enzymes that can inactivate it. Together, they create a highly effective formulation that works against resistant and difficult-to-treat bacterial strains. Uses of Proceftazo 1125 Injection Proceftazo 1125 is widely prescribed for treating various bacterial infections, including: 1. Respiratory Tract Infections Pneumonia Bronchitis Lung abscess 2. Urinary Tract Infections (UTIs) Complicated UTIs Kidney infections 3. Skin and Soft Tissue Infections Cellulitis Wound infections Abscesses 4. Intra-Abdominal Infections Peritonitis Gastrointestinal infections 5. Bone and Joint Infections Osteomyelitis Septic arthritis 6. Bloodstream Infections Sepsis and bacteremia 7. Gynecological Infections Pelvic inflammatory disease Proceftazo 1125 is especially useful in treating infections caused by resistant bacteria, making it a reliable choice in critical care settings. How Proceftazo 1125 Works The combination of Ceftriaxone and Tazobactam provides a dual mechanism of action: Ceftriaxone attacks and destroys bacterial cell walls, leading to bacterial death. Tazobactam inhibits beta-lactamase enzymes produced by bacteria, which would otherwise neutralize Ceftriaxone. This synergistic action ensures: Broader antibacterial coverage Increased effectiveness against resistant strains Faster infection control Key Benefits of Proceftazo 1125 Injection 1. Broad-Spectrum Antibiotic Coverage Proceftazo 1125 is effective against a wide range of Gram-positive and Gram-negative bacteria. 2. Enhanced Resistance Protection Thanks to Tazobactam, this injection overcomes bacterial resistance mechanisms, making treatment more effective. 3. Rapid Action Being an injectable formulation, it works quickly, making it ideal for severe or life-threatening infections. 4. Trusted in Hospital Settings Frequently used in intensive care units (ICUs) and emergency care for serious infections. 5. Reduced Risk of Treatment Failure The combination therapy lowers the chances of antibiotic resistance and relapse. 6. Convenient Dosing Usually administered once or twice daily depending on the severity of infection. Dosage and Administration Proceftazo 1125 is administered via intramuscular (I.M.) or intravenous (I.V.) injection. Dosage depends on: Type and severity of infection Patient’s age and weight Kidney and liver function ⚠️ Always administered by a healthcare professional. Do not self-inject. Possible Side Effects of Proceftazo 1125 While generally well-tolerated, some patients may experience side effects: Common Side Effects Pain or swelling at injection site Diarrhea Nausea or vomiting Rash Moderate Side Effects Allergic reactions Elevated liver enzymes Headache or dizziness Serious Side Effects (Rare) Severe allergic reactions (anaphylaxis) Blood disorders Clostridium difficile-associated diarrhea Kidney or liver dysfunction When to Seek Medical Attention Seek immediate medical help if you experience: Difficulty breathing Severe rash or itching Persistent diarrhea Yellowing of skin or eyes Unusual bleeding Precautions and Warnings Inform your doctor if you have allergies to cephalosporins or penicillin. Use cautiously in patients with kidney or liver disorders. Not recommended for premature infants or newborns without medical advice. Alcohol consumption should be avoided during treatment. Drug Interactions Proceftazo 1125 may interact with: Blood thinners Other antibiotics Diuretics Calcium-containing IV solutions Always inform your doctor about all medications you are taking. Storage Instructions Store below 25°C Protect from light and moisture Keep out of reach of children Conclusion Proceftazo 1125 Injection (Ceftriaxone & Tazobactam) is a highly effective, broad-spectrum antibiotic designed to combat serious and resistant bacterial infections. Its dual-action formula ensures enhanced bacterial killing and protection against resistance, making it a trusted choice in hospitals and critical care settings. With its rapid action, wide applicability, and strong clinical effectiveness, Proceftazo 1125 plays a crucial role in modern infection management. However, it should always be used under strict medical supervision to ensure safety and effectiveness.

Other Specifications

Brand Name :NILOTHERAPY 150
Manufactured By :Steris Healthcare Pvt Ltd
Package SIZE :1125mg inj
Storage :store in cool and dry place
Country :India

Other Products

Related Products

NILOTHERAPY 150 is a prescription medication containing Nilotinib 150 mg, a targeted therapy primarily used in the treatment of certain types of blood cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins responsible for cancer cell growth. This medication is widely prescribed for patients diagnosed with Chronic Myeloid Leukemia (CML), especially those who are resistant or intolerant to other treatments. NILOTHERAPY 150 is designed to provide effective disease control while improving long-term outcomes and quality of life for patients. What is Nilotinib 150 mg? Nilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, an abnormal protein produced in patients with Chronic Myeloid Leukemia. By inhibiting this protein, NILOTHERAPY 150 helps slow down or stop the uncontrolled growth of cancer cells. Unlike traditional chemotherapy, Nilotinib is a targeted therapy, meaning it focuses on cancer cells with minimal damage to healthy cells, making it a more precise and often better-tolerated treatment option. Uses of NILOTHERAPY 150 NILOTHERAPY 150 is primarily prescribed for: 1. Chronic Myeloid Leukemia (CML) Used in adults and children diagnosed with Philadelphia chromosome-positive CML. Effective in both newly diagnosed patients and those who cannot tolerate other treatments like Imatinib. 2. Resistant or Intolerant CML Cases Helps patients who have not responded adequately to first-line therapies. Offers an alternative with improved efficacy in certain resistant mutations. 3. Long-Term Disease Management Helps maintain remission and prevent disease progression to advanced stages such as accelerated or blast phase CML. Key Benefits of NILOTHERAPY 150 1. Targeted Cancer Therapy NILOTHERAPY 150 directly targets cancer-causing proteins, minimizing damage to healthy cells and reducing many of the harsh side effects associated with chemotherapy. 2. High Effectiveness Clinical studies have shown that Nilotinib can achieve faster and deeper molecular responses compared to older treatments. 3. Improved Survival Rates Patients using Nilotinib often experience better long-term survival outcomes when taken as prescribed. 4. Oral Administration Unlike intravenous cancer treatments, NILOTHERAPY 150 is taken orally, making it convenient and easier to incorporate into daily life. 5. Reduced Disease Progression Helps prevent the progression of CML into more aggressive stages, offering better disease control. 6. Suitable for Resistant Cases Effective for patients who do not respond well to first-generation TKIs, providing a second chance at disease management. How NILOTHERAPY 150 Works Nilotinib works by blocking the activity of the BCR-ABL tyrosine kinase enzyme. This enzyme sends signals that tell cancer cells to grow and divide uncontrollably. By inhibiting this signal, NILOTHERAPY 150: Stops cancer cell multiplication Induces cancer cell death Helps restore normal blood cell production Dosage and Administration Typically taken twice daily on an empty stomach (at least 2 hours after a meal and 1 hour before the next meal). Swallow capsules whole with water. Always follow your doctor’s prescribed dosage and schedule. ⚠️ Do not adjust the dose without medical advice. Possible Side Effects of NILOTHERAPY 150 Like all medications, NILOTHERAPY 150 may cause side effects. While not everyone experiences them, it’s important to be aware: Common Side Effects Headache Nausea Fatigue Skin rash Constipation or diarrhea Serious Side Effects Heart rhythm problems (QT prolongation) Liver function abnormalities Pancreatitis Low blood cell counts Increased blood sugar levels When to Seek Medical Help Contact your doctor immediately if you experience: Chest pain or irregular heartbeat Severe abdominal pain Unusual bleeding or bruising Yellowing of skin or eyes Precautions and Warnings Inform your doctor if you have a history of heart disease, liver problems, or electrolyte imbalances. Avoid grapefruit and grapefruit juice as they may interfere with the drug’s effectiveness. Regular blood tests and monitoring are essential during treatment. Not recommended during pregnancy or breastfeeding unless advised by a healthcare professional. Drug Interactions NILOTHERAPY 150 may interact with other medications, including: Antifungal drugs Antibiotics Heart medications Certain antidepressants Always inform your healthcare provider about all medicines and supplements you are taking. Storage Instructions Store in a cool, dry place below 25°C Keep away from direct sunlight and moisture Keep out of reach of children Conclusion NILOTHERAPY 150 (Nilotinib 150 mg) is a highly effective, targeted treatment for Chronic Myeloid Leukemia, offering patients a modern alternative to traditional chemotherapy. Its ability to specifically inhibit cancer-causing proteins makes it a powerful tool in controlling disease progression and improving long-term survival.
View Details
Nilotinib 150mg

INR3270

NILOTHERAPY 200 is a targeted anti-cancer medication containing Nilotinib 200 mg, primarily used in the treatment of chronic myeloid leukemia (CML). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal proteins responsible for cancer cell growth. Developed to provide more precise and effective cancer treatment, NILOTHERAPY 200 offers improved outcomes compared to traditional therapies. It is commonly prescribed for patients who are newly diagnosed with CML or those who have not responded well to other treatments. What is Nilotinib and How Does It Work? Nilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, a key driver of leukemia cell growth. Mechanism of Action Blocks abnormal signals that promote cancer cell multiplication Stops the growth and spread of leukemia cells Helps restore normal blood cell production Unlike chemotherapy, which affects both healthy and cancerous cells, Nilotinib works in a targeted manner, reducing damage to normal cells and improving treatment tolerability. Uses of NILOTHERAPY 200 1. Treatment of Chronic Myeloid Leukemia (CML) NILOTHERAPY 200 is widely used for: Newly diagnosed Philadelphia chromosome-positive CML Chronic phase and accelerated phase CML Patients resistant or intolerant to prior therapies 2. Long-Term Disease Control It helps maintain remission and prevents disease progression when taken regularly as prescribed. 3. Alternative to First-Line Therapies For patients who do not respond well to other medications, NILOTHERAPY 200 serves as an effective alternative. Key Benefits of NILOTHERAPY 200 1. Targeted Cancer Therapy NILOTHERAPY 200 specifically attacks cancer cells without extensively harming healthy cells, making it more precise than conventional chemotherapy. 2. High Effectiveness in CML Management Clinical studies have shown that Nilotinib provides: Faster molecular response Improved long-term survival rates Reduced risk of disease progression 3. Oral Convenience The capsule form allows patients to take the medication at home, avoiding frequent hospital visits. 4. Improved Quality of Life Patients often experience fewer severe side effects compared to traditional treatments, enabling better daily functioning. 5. Suitable for Resistant Cases Effective in patients who have developed resistance to earlier therapies like imatinib. Dosage and Administration Typically taken twice daily, approximately 12 hours apart Must be taken on an empty stomach (avoid food 2 hours before and 1 hour after) Swallow capsules whole with water Follow your doctor’s exact dosage instructions Important Tip Do not skip doses or stop treatment without medical advice, as this may affect treatment outcomes. Possible Side Effects of NILOTHERAPY 200 Like all medications, NILOTHERAPY 200 may cause side effects. While many are manageable, some require immediate attention. Common Side Effects Headache Nausea Fatigue Constipation or diarrhea Muscle or joint pain Serious Side Effects Heart rhythm problems (QT prolongation) Liver function abnormalities Pancreatitis Low blood cell counts Sudden weight gain or swelling When to Seek Medical Help Contact your doctor immediately if you experience: Irregular heartbeat Severe abdominal pain Yellowing of skin or eyes Unusual bleeding or bruising Precautions and Warnings Before starting NILOTHERAPY 200, consider the following: Inform your doctor if you have heart disease, liver problems, or electrolyte imbalance Regular ECG monitoring may be required Avoid grapefruit and grapefruit juice during treatment Not recommended during pregnancy unless prescribed Use effective contraception during treatment Drug Interactions Nilotinib may interact with: Antifungal medications Antibiotics Heart rhythm drugs Antacids Always inform your healthcare provider about all medicines and supplements you are taking. Storage Instructions Store below 30°C in a dry place Keep away from moisture and direct sunlight Keep out of reach of children Why Choose NILOTHERAPY 200? Nilotherapy 200 stands out due to the following: Advanced targeted therapy mechanism Proven success in treating CML Convenient oral dosage Effective in resistant and intolerant cases Trusted pharmaceutical quality Conclusion NILOTHERAPY 200 (Nilotinib 200 mg Capsules) is a powerful and reliable treatment option for patients with chronic myeloid leukemia. Its targeted mechanism, high effectiveness, and convenient oral administration make it a preferred choice among healthcare professionals.
View Details
Nilotinib 200mg

INR3570

Introduction to Defrosia 500 Defrosia 500 is a clinically trusted iron chelation medicine containing Deferasirox 500 mg in dispersible tablet form. It is widely prescribed for patients suffering from chronic iron overload, a condition commonly caused by repeated blood transfusions in disorders such as thalassemia, sickle cell anemia, and other chronic anemias. Excess iron accumulation in the body can damage vital organs like the liver, heart, and endocrine glands. Defrosia 500 works effectively to remove this excess iron, helping patients maintain a healthier life and prevent long-term complications. What is Deferasirox and How Does It Work? Deferasirox is an oral iron chelator that binds to excess iron in the bloodstream. Once bound, the iron is removed from the body through stool, reducing iron levels safely over time. Unlike older treatments that required injections, Defrosia 500 dispersible tablets offer a convenient, once-daily oral solution, improving patient compliance and comfort. Uses of Defrosia 500 Defrosia 500 is primarily prescribed for: 1. Chronic Iron Overload Due to Blood Transfusions Patients with conditions like the following: Thalassemia major Sickle cell disease Myelodysplastic syndromes often require frequent blood transfusions, leading to iron accumulation. Defrosia 500 helps remove this excess iron effectively. 2. Non-Transfusion Dependent Iron Overload It is also used in patients who accumulate iron naturally without regular transfusions. 3. Prevention of Organ Damage By controlling iron levels, Defrosia 500 helps prevent: Liver cirrhosis Heart complications Hormonal imbalances Key Benefits of Defrosia 500 1. Effective Iron Removal Defrosia 500 binds excess iron and eliminates it, reducing toxic buildup in the body. 2. Once-Daily Oral Dosage Unlike injectable chelation therapies, Defrosia 500 is taken orally, making it more convenient and patient-friendly. 3. Protects Vital Organs Regular use helps safeguard critical organs such as the following: Liver Heart Pancreas 4. Improves Quality of Life By reducing iron overload symptoms like fatigue and weakness, patients experience improved overall well-being. 5. Dispersible Form for Easy Consumption The tablet dissolves in liquid, making it easier for patients who have difficulty swallowing pills. How to Take Defrosia 500 Take the medicine once daily on an empty stomach or as prescribed by your doctor. Dissolve the tablet in water, orange juice, or apple juice before consumption. Do not chew or swallow the tablet whole. Follow your doctor’s dosage instructions carefully based on your body weight and iron levels. Possible Side Effects of Defrosia 500 Like all medications, Defrosia 500 may cause side effects. Most are mild, but some may require medical attention. Common Side Effects Nausea or vomiting Diarrhea Abdominal pain Skin rash Serious Side Effects (Seek Medical Help) Kidney problems (reduced urine, swelling) Liver issues (yellowing of skin or eyes) Hearing or vision disturbances Severe allergic reactions Monitoring is important. Doctors usually recommend regular tests such as the following: Serum ferritin levels Kidney function tests Liver function tests to ensure safe and effective treatment. Precautions and Warnings Before using Defrosia 500, consider the following: Inform your doctor if you have kidney or liver disease Not recommended for patients with severe kidney impairment Use with caution in elderly patients Avoid during pregnancy unless prescribed Not suitable for children under medical supervision without guidance Drug Interactions Defrosia 500 may interact with certain medications such as: Antacids containing aluminum Blood thinners Certain antibiotics Always inform your healthcare provider about all medications and supplements you are taking. Storage Instructions Store in a cool, dry place Keep away from direct sunlight Keep out of reach of children Why Choose Defrosia 500? Defrosia 500 stands out due to: Proven effectiveness in iron chelation Convenient dispersible formulation Reduced need for invasive treatments Trusted quality and safety profile It is a preferred choice among healthcare professionals for managing iron overload conditions. Conclusion Defrosia 500 (Deferasirox Dispersible Tablets 500 mg) is a highly effective and convenient treatment for managing chronic iron overload. With its once-daily oral dosing and strong safety profile, it helps patients maintain optimal iron levels and prevent serious complications affecting the liver, heart, and other organs.
View Details
deferasirox dispersible tablets 500mg

INR395

Have any question or need any business consultation?

Contact Us

Have any question or need any business consultation?

Contact Us
Chat with us